Singapore

This comes as injewelme prepares to deploy its proprietary technology following trials with SingHealth Polyclinics.

Also, Neurophet has raised over $20 million for the development and global expansion of its AI-based brain imaging analysis software suite.

Engineers from the National University of Singapore plan to further develop the sensor to continuously monitor mental health conditions.

A community trial has shown that the data-driven, fall-detecting wearable robot developed at Nanyang Technological University requires less physiotherapist assistance.

Private rheumatologist Dr Anandita Santosa in Singapore notes how current AI in healthcare priorities practically leave autoimmune and rheumatic diseases behind and shares what can be done to build a more comprehensive AI-driven preventive care ecosystem.

Clinician innovators across the region see the next phase of healthcare AI focusing on trust and responsible adoption after a year of rapid experimentation.

Predictions from Australia to Southeast Asia highlight where AI, telehealth, and platform consolidation are headed next.

AeviceMD says it has yet to conduct pilot deployments, which would focus on incorporating respiratory monitoring into outpatient asthma management pathways.

Respiree is also preparing to file for regulatory approval for its AI tool in the United States and across Australia, New Zealand, and Asia.

Former Zuellig Pharma exec Louis Payet launches Peach Health Asia, aiming to make coach-guided tele-physiotherapy and digital rehabilitation accessible across Southeast Asia.